Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.23
+0.22 (0.92%)
At close: Sep 2, 2025, 4:00 PM
24.21
-0.02 (-0.08%)
After-hours: Sep 2, 2025, 4:40 PM EDT
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $702.87 million as of September 2, 2025. Its market cap has decreased by -6.63% in one year.
Market Cap
702.87M
Enterprise Value
458.49M
1-Year Change
-6.63%
Ranking
Category
Stock Price
$24.23
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $702.87M, an increase of 471.20%. That is a compound annual growth rate of 32.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 702.29M | -5.91% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | 1.62B | 176.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |